|
MKLN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.211300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.980800E-04 |
| Normal-vs-Stage2 |
4.098400E-01 |
| Normal-vs-Stage3 |
7.162000E-03 |
| Normal-vs-Stage4 |
4.997500E-04 |
| Stage1-vs-Stage2 |
4.753800E-01 |
| Stage1-vs-Stage3 |
8.100200E-01 |
| Stage1-vs-Stage4 |
2.363800E-01 |
| Stage2-vs-Stage3 |
4.659000E-01 |
| Stage2-vs-Stage4 |
2.159600E-01 |
| Stage3-vs-Stage4 |
5.237600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.023940E-03 |
| Normal-vs-AfricanAmerican |
2.782200E-02 |
| Normal-vs-Asian |
2.053800E-02 |
| Caucasian-vs-AfricanAmerican |
9.948800E-01 |
| Caucasian-vs-Asian |
6.507200E-01 |
| AfricanAmerican-vs-Asian |
6.941000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.3619999999931E-05 |
| Normal-vs-Female |
4.887200E-01 |
| Male-vs-Female |
2.826100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.581690E-02 |
| Normal-vs-Extreme_Weight |
8.446200E-04 |
| Normal-vs-Obese |
6.200500E-02 |
| Normal-vs-Extreme_Obese |
5.731600E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.017200E-01 |
| Normal_Weight-vs-Obese |
3.487000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.400000E-01 |
| Extreme_Weight-vs-Obese |
2.057600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.560200E-01 |
| Obese-vs-Extreme_Obese |
2.517800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.544160E-01 |
| Normal-vs-Age(41-60Yrs) |
6.598200E-02 |
| Normal-vs-Age(61-80Yrs) |
6.38330000000131E-05 |
| Normal-vs-Age(81-100Yrs) |
1.475030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.936000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.090000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.883800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.292200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.666800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.086600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.485730E-02 |
| Normal-VS-Type2 PRCC |
1.038140E-03 |
| Normal-VS-KIRP CIMP |
2.405000E-01 |
| Normal-VS-Unclassified PRCC |
1.097840E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.370400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.145200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.070800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.384800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.853000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.401800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.84590000005003E-06 |
| Normal-vs-N1 |
3.338300E-02 |
| Normal-vs-N2 |
3.846100E-02 |
| N0-vs-N1 |
8.301900E-02 |
| N0-vs-N2 |
7.963800E-01 |
| N1-vs-N2 |
5.730400E-01 |
|
|
